<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Sonoma Pharmaceuticals, Inc. — News on 6ix</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc</link>
<description>Latest news and press releases for Sonoma Pharmaceuticals, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 24 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/sonoma-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c21378dffbe2df1192d7.webp</url>
<title>Sonoma Pharmaceuticals, Inc.</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc</link>
</image>
<item>
<title>Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-pricing-of-dollar4-million-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-pricing-of-dollar4-million-public-offering</guid>
<pubDate>Fri, 24 Apr 2026 04:00:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / April 24, 2026 / Sonoma Pharmaceuticals, Inc. (the "Company" or "Sonoma Pharmaceuticals") (NASDAQ:SNOA), a global healthcare</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-us-retail-launch-of-advanced-burn-relief-hydrogel-in-cvs-and-walmart</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-us-retail-launch-of-advanced-burn-relief-hydrogel-in-cvs-and-walmart</guid>
<pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / March 24, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in hypochlorous acid (HOCl)</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-launch-of-new-dermatology-product-line-under-person-and-coveys-aquanil-brand-for-sensitive-skin</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-launch-of-new-dermatology-product-line-under-person-and-coveys-aquanil-brand-for-sensitive-skin</guid>
<pubDate>Wed, 18 Mar 2026 04:00:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-third-fiscal-211000465</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-third-fiscal-211000465</guid>
<pubDate>Tue, 10 Feb 2026 21:10:00 GMT</pubDate>
<description>Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior year Net loss and net loss per share decreased from prior year for both the three months and nine months ended December ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-welcomes-member-board-211500759</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-welcomes-member-board-211500759</guid>
<pubDate>Wed, 28 Jan 2026 21:15:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of ...</description>
</item>
<item>
<title>National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/national-rosacea-society-awards-seal-133000656</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/national-rosacea-society-awards-seal-133000656</guid>
<pubDate>Thu, 13 Nov 2025 13:30:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-exhibit-medica-2025-210100382</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-exhibit-medica-2025-210100382</guid>
<pubDate>Thu, 06 Nov 2025 21:01:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-second-fiscal-135600100</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-second-fiscal-135600100</guid>
<pubDate>Tue, 04 Nov 2025 13:56:00 GMT</pubDate>
<description>Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last year U.S. revenue increased 115% for the quarter and 86% for the six months ended September 30, 2025 compared to same periods ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-medline-industries-launch-123000926</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-medline-industries-launch-123000926</guid>
<pubDate>Tue, 14 Oct 2025 12:30:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products based on its patented Microcyn® technology, today announced ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-expands-market-reach-123000924</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-expands-market-reach-123000924</guid>
<pubDate>Tue, 07 Oct 2025 12:30:00 GMT</pubDate>
<description>BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products, today announced ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-participate-lytham-partners-200100870</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-participate-lytham-partners-200100870</guid>
<pubDate>Thu, 25 Sep 2025 20:01:00 GMT</pubDate>
<description>BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide ...</description>
</item>
<item>
<title>National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/national-psoriasis-foundation-awards-seal-123000003</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/national-psoriasis-foundation-awards-seal-123000003</guid>
<pubDate>Tue, 26 Aug 2025 12:30:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-launch-diaper-200100151</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-launch-diaper-200100151</guid>
<pubDate>Wed, 13 Aug 2025 20:01:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-first-fiscal-201500111</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-first-fiscal-201500111</guid>
<pubDate>Thu, 07 Aug 2025 20:15:00 GMT</pubDate>
<description>Revenues increased 18% compared to same period last year U.S. revenue increased 57% compared to same period last year Net loss per share decreased 43% compared to same period last year BOULDER, COLORADO / ACCESS Newswire / August 7, 2025 / Sonoma ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-fiscal-fourth-201000316</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-fiscal-fourth-201000316</guid>
<pubDate>Tue, 17 Jun 2025 20:10:00 GMT</pubDate>
<description>Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024 Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024 EBITDA loss improved 59% in Q4 2025 compared to Q4 2024, and ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-registration-acne-200100540</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-announces-registration-acne-200100540</guid>
<pubDate>Tue, 22 Apr 2025 20:01:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-secures-extensive-u-200100465</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-secures-extensive-u-200100465</guid>
<pubDate>Mon, 10 Mar 2025 20:01:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / March 10, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-exhibit-2025-american-210100285</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-exhibit-2025-american-210100285</guid>
<pubDate>Tue, 25 Feb 2025 21:01:00 GMT</pubDate>
<description>BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of ...</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results </title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-third-fiscal-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-reports-third-fiscal-quarter-2025-financial-results</guid>
<pubDate>Wed, 05 Feb 2025 05:00:00 GMT</pubDate>
<description>Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash</description>
</item>
<item>
<title>Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices</title>
<link>https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-successfully-transitions-first-products-to-new-eu-mdr-requirements-for-class-iib-medical-devices</link>
<guid isPermaLink="true">https://6ix.com/company/sonoma-pharmaceuticals-inc/news/sonoma-pharmaceuticals-successfully-transitions-first-products-to-new-eu-mdr-requirements-for-class-iib-medical-devices</guid>
<pubDate>Thu, 05 Dec 2024 05:00:00 GMT</pubDate>
<description>BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented</description>
</item>
</channel>
</rss>